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E-mail address: sallese@negrisud.it (M. Sallese).The KDEL receptor is a seven-transmembrane-domain protein that was ﬁrst described about 20
years ago. Its well-known function is to retrotransport chaperones from the Golgi complex to the
endoplasmic reticulum. Recent studies, however, have suggested that the KDEL receptor has addi-
tional functions. Indeed, we have demonstrated that chaperone-bound KDEL receptor triggers the
activation of Src family kinases on the Golgi complex. This activity is essential in the regulation of
Golgi-to-plasma membrane transport. However, the identiﬁcation of different KDEL receptor inter-
actors that are inconsistent with these established functions opens the possibility of further recep-
tor activities.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction and historic perspective
The secretory pathway includes a number of anatomically sep-
arate compartments that constantly exchange their membranes
and proteins in an organised sequence of events [1,2]. Newly syn-
thesised proteins enter the endoplasmic reticulum (ER) and move
on to the Golgi complex, where they are modiﬁed prior to being
distributed to their ﬁnal destinations [3].
In the 1980s, the concept that newly synthesised proteins fold
spontaneously began to change in favour of a chaperone-driven
mechanism. This followed the identiﬁcation and cloning of endo-
plasmic reticulum (ER)-resident proteins that are involved in the
folding of nascent transmembrane and secretory proteins. These
ﬁndings, however, led to more questions, such as how and where
these ER-resident proteins are sorted out from newly synthesised
secretory proteins.chemical Societies. Published by E
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peptide motif (the KDEL motif in mammals, HDEL in yeast) that
is shared by several ER chaperones, including glucose-regulated
protein-78 (GRP78), glucose-regulated protein-94 (GRP94) and
protein disulphide isomerase (PDI). They hypothesised that the
KDEL/HDEL motif acts as an ER retention/retrieval signal to keep
the chaperones in the ER.
The proof of concept was provided with the addition of the last
six amino-acid residues of GRP78 to the C-terminus of an exoge-
nous protein (lysozyme) engineered to be luminal and to cross
the secretory pathway; this prevented its secretion, with its conse-
quent accumulation in the ER [4]. Analyses of the carbohydrate
modiﬁcations of an artiﬁcial HDEL-tagged yeast secretory protein
(invertase) suggested that ER-resident chaperone proteins can
leave the ER, undergo Golgi-speciﬁc modiﬁcations, and then return
to the ER [5–7]. This thus suggested that the HDEL motif is part of a
retrieval, rather than a retention, mechanism. Indeed, overexpres-
sion of an HDEL-tagged exogenous protein leads to increased
secretion of the endogenous yeast chaperone GRP78, indicating
that the HDEL retention system can be saturated by HDEL ligands
and that chaperone retrieval into the ER is mediated by a speciﬁc
receptor [7].
To identify the HDEL receptor and the components involved in
the ER-retention system, several ER-retention defective (erd) yeast
mutants were obtained by UV-induced random mutagenesis [6].
These mutants failed to retain HDEL-tagged invertase and endoge-
nous GRP78 in the ER. Functional complementation of these mu-
tants led to the identiﬁcation of two genes, ERD1 and ERD2 [8,9].lsevier B.V. All rights reserved.
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of which indeed leads to secretion of HDEL-tagged proteins,
although unexpectedly, these yeasts show defects in the N-glyco-
sylation of their secreted proteins [8]. The ERD2 gene also encodes
an integral membrane protein that is localised in the ER and the
Golgi complex, the deletion of which leads to secretion of HDEL-
tagged proteins. The overexpression of the ERD2 gene in erd2-de-
leted mutant cells restored their ability to retain GRP78 and artiﬁ-
cial HDEL-containing fusion proteins in the ER. Furthermore, in a
yeast strain with deletion of its endogenous ERD2 and carrying
one copy of the ERD2 gene on a centromere-containing expression
vector, an HDEL-tagged invertase fusion protein was not retained
in the ER, indicating that the efﬁciency of this retrieval system de-
pends on the level of the HDEL receptor, Erd2p [9].
In addition to these alterations to the HDEL retention system,
erd2-deletion mutant yeast also accumulate intracellular mem-
branes, concomitant with the inhibition of secretory protein trans-
port through the Golgi complex. This suggests that there are
transport defects in the ER and the Golgi complex. It has been
hypothesised that both defects (in the retention of HDEL-contain-
ing ER proteins, and in secretion) are related, since ERD2 might
be necessary not only for retrieval of ER proteins, but also for
recycling of other components that are necessary for anterograde
trafﬁcking [9]. Notably, erd2-deﬁcient yeast gradually become qui-
escent and cease to grow.
To determine the role of Erd2p in the Golgi complex and why it
is essential for yeast growth, multicopy suppressor screening of the
growth phenotype induced in erd2-deletion mutant cells has been
carried out [10]. This led to the identiﬁcation of six genes, called
suppressors of erd2-deletion (SED) 1–6. SED1 is a stress-response
gene that encodes a cell-wall protein that appears to be involved
in the maintenance of mitochondrial genome stability [11]. SED2
is also known as SEC12, and it is a guanine nucleotide exchange fac-
tor (GEF) that is involved in the exit of cargo from the ER, as anTable 1
Protein identities and similarities across the different KDEL/HDEL receptor isoforms. The
penalty, 10.0; Gap extension penalty, 0.5) at www.ebi.ac.uk.activator of the small GTPase Sar1, the master regulator of COPII
coat complex formation [12]. SED3 is also known as DPM1, and it
is a dolichol-phosphate mannose synthase, an enzyme that is in-
volved in protein glycosylation and formation of glycosylphosphat-
idylinositol (GPI) anchors [13]. SED4 is a transmembrane protein
that has been suggested to work in concert with SED2 to regulate
the activation/ inactivation of Sar1 [14,15]. SED5 is a t-SNARE syn-
taxin protein that is involved in ER-to-Golgi transport [16,17]. Fi-
nally, SED6 is also known as ERG6, and it is a methyltransferase
that is involved in ergosterol synthesis [18].
How these genes compensate for the lack of the ERD2 gene,
however, is not obvious, although it has been proposed that they
can counteract the membrane transport imbalance that results
from the loss of Erd2p [10]. Although the secretory and growth
phenotypes that have been observed for erd2-deleted yeast cells
remain to be explained, we have recently reported on and de-
ﬁned the mechanisms behind a similar secretion defect in
eukaryotic cells expressing a dominant-negative mutant of hu-
man ERD2 [19].2. Cloning and intracellular distribution of the human KDEL
receptor
The recognition of the ERD2 gene as the HDEL receptor in the
yeast Saccharomyces cerevisiae and Kluyveromyces lactis [9,20]
was rapidly followed by the cloning of mammalian orthologues.
By 1990, Lewis and Pelham had identiﬁed the ﬁrst human HDEL
receptor homologue, referred to as hERD2 or the KDEL receptor,
since the KDEL motif is the most common ER-retrieval sequence
in mammals [21]. The hERD2 gene encodes a protein of 214 amino
acids that has about 50% identity with S. cerevisiae and K. lactis
Erd2p. Interestingly, the identity between these two yeast ERD2
genes is only around 60%, suggesting that strong evolutionary pres-analysis was performed using the EMBOSS algorithm (matrix, Blosum62; Open gap
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human.
Two independent laboratories eventually identiﬁed a second
human KDEL receptor that is functionally identical to ﬁrst human
KDEL receptor, with about 83% identity (Table 1) [22,23]. This
new gene was named KDEL receptor 2 and ELP-1.
The KDEL receptor localises preferentially to the Golgi complex,
the ER (similar to yeast) and the intermediate ER-Golgi compart-
ment (ERGIC). The expression of an artiﬁcial ligand, such as
KDEL-tagged lysozyme, results in redistribution of the KDEL recep-
tor into the ER, a phenomenon that is reminiscent of the ligand-in-
duced internalisation of the G-protein-coupled receptors (GPCRs).
Electron microscopy studies have conﬁrmed and better deﬁned
the presence of the KDEL receptor in the ER, the ERGIC and the Gol-
gi complex [24]. Quantitative examination has revealed that the
KDEL receptor is mainly localised in the ERGIC and the cis-side of
the Golgi complex, which contains ﬁvefold more KDEL receptor
labelling than the medial and trans parts of the Golgi complex
[25]. Instead, the endosomal compartment is almost devoid of
KDEL receptor staining [24]. Of note, the distribution of the KDEL
receptor generally overlaps with that of the chaperones [24].
Under stress conditions, such as with virus infection, tempera-
ture shifts or increased cargo loading of the secretory pathway,
the distribution of the KDEL receptor is modiﬁed, so that high lev-
els are then found even on the TGN [24]. This can be explained con-
sidering that in situations with heavy trafﬁc loads, the sorting of
the KDEL receptor at the Golgi complex is not efﬁcient, and as a re-
sult its localisation on the TGN is increased. It would be interesting
to investigate the consequences of this redistribution on the func-Table 2
KDEL receptor nomenclature in human and Saccharomyces cerevisiae.tioning of the KDEL receptor. Thus far, the role of cell stress with
KDEL receptor expression is still controversial, since it has been re-
ported that cell stress causes receptor overexpression in yeast and
plants [26,27], whereas it might remain unchanged in mammals
[28].
A third KDEL receptor was identiﬁed in the late 1990s, during
the genome and ORFeome sequencing project [29]. Although lack-
ing formal experimental evidence, it appears that KDEL receptor 3
exists in two spliced isoforms (a and b, or alternatively, 1 and 2).
These encode two proteins of 220 amino acids that differ one
from the other in their last 19 C-terminal amino acids, due to a
fourth intron in the longer isoform (b or 2) [30]. However, thus
far, only KDEL receptor 3a has been partially characterised, and it
shows a Golgi localisation, as seen for the other KDEL receptors
[31].
Along the years, the KDEL receptor class of proteins has been
associated with different names; in Table 2, we have summarised
the different deﬁnitions that have been attributed to the human
and yeast KDEL receptors. Here, we propose to use the gene names
given in the ﬁrst column of Table 2 to indicate these genes (e.g.
KDELR1), and the protein names given on the third column to indi-
cate these proteins (e.g. KDEL receptor 1).
Sequence analyses of the human KDEL receptor proteins show a
signiﬁcant degree of conservation, since their identities range from
65.0% to 83.5% (Table 1), while their homologies increase from
80% to 94% (Table 1), suggesting that they might have redun-
dant functions, although with some degree of speciﬁcity possible.
During evolution from yeast to human, the gene coding for the
KDEL receptor has undergone triplication, and there are indications
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variants (http://harvester.fzk.de/harvester/ and [31]), emphasising
the importance of this protein for cell function. As expected for
proteins committed to basic cell functions (retrieval of ER chaper-
ones), each of the KDEL receptor isoforms are expressed in all hu-
man tissues, although to different extents; this generally follows a
common pattern, with KDELR1 more transcribed than KDELR2,
which is in turn more transcribed than KDELR3 [31,32] (http://
www.genecards.org).
The speciﬁcities of the three KDEL receptors have been
addressed more recently by Ruddock and co-workers [31], who
applied bimolecular-ﬂuorescence-complementation-based screen-
ing. They demonstrated that each of the KDEL receptor isoforms
binds preferentially to a speciﬁc set of KDEL-like sequences
[31]. This study also showed that KDEL receptor 1 and KDEL
receptor 3 are less specialised than KDEL receptor 2 in their abil-
ities to bind and retrieve into the ER any KDEL-motif variants.
Within this general classiﬁcation, and taking into consideration
the two most frequent C-terminal motifs in the human ER chap-
erones (KDEL and HDEL), KDEL receptor 1 preferentially binds
chaperones bearing the KDEL over the HDEL motif, whereas KDEL
receptor 3 strongly favours the HDEL motif over the KDEL motif.
In contrast, the specialised KDEL receptor 2 preferentially recog-
nises variants of the HDEL motif over any other. The functional
signiﬁcance of these different binding speciﬁcities, however, still
remains to be deﬁned. We can at present hypothesise that each
KDEL receptor can recognise a sub-population of KDEL ligands,
the expression and presence of which outside the ER can change
in response to cellular stimuli or physiopathological conditions;
as a result, each individual KDEL receptor isoform might generate
a speciﬁc outcome.
3. Structural and functional relationships of the KDEL receptor
As an initial attempt to reveal the structural organisation of the
KDEL receptor, hydropathy analyses of the yeast and human KDEL
receptors were carried out. These have provided evidence of an
integral membrane protein with seven-transmembrane domains
[9]. This prediction has since been conﬁrmed experimentally in dif-
ferent studies, which have also located the N-terminal region of the
KDEL receptor to the lumen of the organelles and the C-terminus to
the cytosol [33,34].
An alternative topology has been reported for the KDEL recep-
tor: six membrane-spanning domains with both the N-terminus
and the C-terminus located in the cytoplasm; this was seen by
tagging the KDEL receptor with c-myc and the N-glycosylation
sites along the protein [35]. This six-transmembrane-domain
model has been little considered, however, as a number of sub-
sequent studies have generated consensus for the seven-trans-
membrane-domain model by analysing their ﬁndings with a
view to this latter topology. The presence of this seven-trans-
membrane-domain architecture (which is reminiscent of the
GPCR family; see below) promoted in vitro ligand-binding stud-
ies, which have been aimed at demonstrating that the KDEL
receptor can bind KDEL peptides. In these studies, microsomal
membranes bearing the KDEL receptor were shown to have spe-
ciﬁc binding activities for KDEL-like-containing peptides. The
afﬁnities were higher for the KDEL and HDEL motifs, and lower
for other KDEL variants, such as DDEL and HDEV. In addition,
from these studies, it has emerged that the afﬁnity of the KDEL
receptor for KDEL ligands does not depend on a speciﬁc lipid
environment [36], while it does dependent on pH. Indeed, under
acid conditions, KDEL receptor–KDEL ligand binding is very efﬁ-
cient; however, at neutral or basic pH, this binding becomes sig-
niﬁcantly weaker [37]. This would suggest that the association of
the KDEL-containing proteins with the KDEL receptor in the Golgicomplex and their release into the ER can be explained by the pH
difference between these two organelles, as the cis-Golgi pH is
lower than that in the ER [38,39].
The relationships between the KDEL receptor structure and
function have been investigated by mutational analysis. In the
yeast K. lactis, it has been reported that the KDEL receptor N51 res-
idue is involved in the speciﬁcity of ligand recognition. Indeed, an
N51D mutation impaired recognition of the HDEL motif, but not of
the DDEL motif, indicating that a single amino-acid residue can
inﬂuence the binding speciﬁcity of the KDEL receptor [40].
The human KDEL receptor has been extensively studied
according to more than 80 different mutations [34]. In general,
mutations in the cytoplasmic loops of the KDEL receptor affect
transport between the ER and the Golgi complex, while they have
minor effects on ligand binding. In contrast, mutations in the
luminal regions or in the peri-luminal moiety of the transmem-
brane domains usually alter KDEL receptor binding, but not the
KDEL receptor distribution, unless the altered distribution is a
consequence of the binding defects. It is worth noting that muta-
tion of D193 in the KDEL receptor, which is localised in the sev-
enth transmembrane region, does not impair KDEL binding
activity in vitro, but fails to redistribute the KDEL receptor into
the ER and prevents the KDEL receptor from retrieving KDEL-con-
taining proteins. This suggests that D193 is a part of an essential
inter-molecular or intra-molecular interaction(s) that is required
for retrograde transport of the KDEL receptor. More recently,
our group has demonstrated that the KDEL receptor D193N-mu-
tant also acts as a functional dominant negative towards endoge-
nous KDEL receptors [19].
Using a sulphydryl-speciﬁc labelling approach, the ligand-bind-
ing pocket of the KDEL receptor has been deﬁned, with the identi-
ﬁcation of four essential amino-acid residues: R5, D50, Y162 and
N165 [33]. These amino acids are well conserved among all of
the KDEL receptors, they are part of the ﬁrst, second and sixth
transmembrane regions of the KDEL receptor, and they are in-
volved in the binding of the KDEL ligands. Interestingly, the D50C
mutation in the human KDEL receptor impairs the binding of
KDEL-, HDEL- and RDEL-containing peptides. Conversely, the bind-
ing afﬁnity for a DDEL peptide was not affected, indicating that res-
idue D50 is involved in mediating the ligand speciﬁcity of the KDEL
receptor. This presumably occurs through an interaction with a
positively charged amino acid at position 4 of the ligands. In
our opinion, several structural and functional features that have
been observed for the KDEL receptor are particularly reminiscent
of the GPCR superfamily. The GPCRs are a large family of proteins
that have a characteristic seven-transmembrane-domain, helical
organisation that is involved in the transduction of extracellular
signals into the cell [41].
The GPCR ligand-binding sites are generally formed of charged
amino-acids embedded inside a hydrophobic seven-helix bundle
[41,42]. Agonist binding induces conformational changes to
GPCRs, which in some cases involve dimerisation [43], and these
lead to the activation of heterotrimeric G-proteins on the cyto-
plasmic side of the plasma membrane, and in turn, to the pro-
duction of second messengers [41]. This signalling is quenched
upon receptor phosphorylation by second-messenger-dependent
protein kinases (PKA and PKC) and GPCR kinases [44,45]. Recep-
tor phosphorylation promotes uncoupling of the G proteins and
recruitment of adaptor proteins (arrestins), which initiates recep-
tor internalisation into the endosomal compartment [44]. These
internalised GPCRs release their ligands and are recycled back
to the plasma membrane [44].
As indicated above, and as with the GPCRs, the KDEL receptor
has a seven-transmembrane-domain organisation with a ligand-
binding site formed by charged amino acids embedded in a
hydrophobic core [33]. Ligand binding induces a conformational
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interacts with heterotrimeric G proteins (our unpublished obser-
vations, and [47]). Furthermore, the KDEL receptor can be phos-
phorylated by PKA, which promotes recruitment of the adaptor
proteins (coat protein complex (COP) I) that are important for
receptor translocation [48]. Finally, the KDEL receptor ligands de-
tach upon their arrival in the destination compartment (ER), and
the KDEL receptor is recycled back to the original membranes (in
the Golgi) [9,49].
These similarities also extend to the functional aspects of the
KDEL receptor, as the properties of the KDEL receptor indicated
above make it a signalling protein [19,50] (see below for details).
4. Molecular machinery involved in KDEL-receptor-dependent
retrieval of ER chaperones
Overexpression of the KDEL receptors has revealed that their
intracellular distributions are dynamic and relate to their levels
of expression. At low levels, the KDEL receptors preferentially
localise on the Golgi complex, whereas at high levels they have
reticular ER-like patterns. This suggests that high expression levels
of the KDEL receptor can induce ligand-independent auto-activa-
tion, which in turn enhances retrograde transport from the Golgi
complex to the ER [23]. This massive receptor auto-activation
can promote the cytosolic redistribution of ADP-ribosylation factor
1 (ARF1, the master regulator of membrane trafﬁcking) and COPI (a
set of seven proteins under the control of ARF1 that is necessary for
formation of retrograde transport carriers), and the collapse of the
Golgi complex into the ER. This phenotype induced by the overex-
pression of the KDEL receptor is similar to that generated by treat-
ment of cells with the fungal toxin brefeldin A (BFA) [51]. BFA
inhibits the ARF guanine nucleotide exchange factors (ARFGEFs),
which reduces the activation of ARF, prevents recruitment of COPI
to the Golgi complex, and promotes redistribution of the Golgi
membranes into the ER.
An extensive study of the KDEL receptor has led to the identiﬁ-
cation of several interactors through which the KDEL receptor can
affect the early secretory pathway. Indeed, the KDEL receptor can
physically interact with ARF1, ARF GTPase-activating protein 1
(ARF-GAP1), b-COP (a subunit of COPI), the p24 family of Golgi/
ER transmembrane proteins (components of the ARF1 complex)
and several SNARE proteins, including mSec22b, mUse1 and
mSec20/BNIP1 [46,52–54].
To shed more light on the behaviour of different KDEL receptor
interactors, the spatio-temporal relationships between these inter-
actors and the KDEL receptor have been investigated following the
binding of KDEL ligands. This binding induces KDEL receptor
dimerisation/oligomerisation [46], strongly increases its interac-
tions with ARFGAP1, ARF1 and COPI, and decreases its interactions
with the p24 family proteins [52].
Of note, since the formation of KDEL receptor interaction com-
plexes depends on the activation status of the KDEL receptor
[46,55], this might explain the BFA-like phenotype that can be seen
in cells overexpressing the KDEL receptor. Here, KDEL receptor
auto-activation recruits large amounts of ARFGAP1, which leads
to the complete inactivation of ARF1. As indicated, ARF1 inactiva-
tion is at the basis of the Golgi redistribution phenotype promoted
by BFA [51].
To summarise, the available data demonstrate that during
membrane transport, chaperones enter the secretory pathway in
cargo-containing carriers and arrive at the Golgi complex. Here,
they bind to the KDEL receptor, for the recruitment of a number
of interactors, which leads to the formation of retrograde transport
carriers, and ﬁnally to the retrieval of KDEL-containing chaperones
and the KDEL receptor to the ER.5. Exploitation of the KDEL receptor for cell intoxication
As an endogenous system for retrograde transport of proteins,
the KDEL receptor can be hijacked by toxins that need to be trans-
ported retrogradely along the secretory pathway to the ER. Some of
the bacterial toxins enter the cell through the endocytic pathway,
and cross the secretory system to reach the ER, where they use
the ER translocon sec61p complex to enter the cytosol and bind
to their targets [56,57]. Among these, some protein toxins, like
the A-fragment of cholera toxin, the heat labile toxin LT1 produced
by Escherichia coli, and Pseudomonas exotoxin A, have evolved a
KDEL or a KDEL-like motif at their C-terminus to exploit the KDEL
receptor as a shuttle for more efﬁcient transport from the Golgi
complex to the ER. Although important, this transport mechanism
is not essential for some toxins; indeed, mutation of the KDEL se-
quence in the A-fragment of cholera toxin does not completely in-
hibit its toxicity. This suggests that retrograde transport of the
cholera toxin A-fragment can also use a pathway that is indepen-
dent of the KDEL receptor [58].
A particular system of retrograde transport is seen in Pseudomo-
nas exotoxin A. This toxin ends with an RDELK sequence, and as
such, it cannot bind to the KDEL receptor. However, prior to entry
into host cells, the lysine of the RDELK sequence is removed by pro-
teases, and thus the toxin acquires the ability to bind to the KDEL
receptor in the Golgi complex, for its retrograde transport to the ER
[59]. Furthermore, intoxication by Pseudomonas exotoxin A is
strictly dependent on the KDEL receptor retrieval system, since
mutations in the RDELK signal, microinjection of antibodies against
the KDEL receptor, or expression of lysozyme-KDEL (which satu-
rates the KDEL receptor retrieval activity) protect against Pseudo-
monas exotoxin A [60]. It would therefore be worth investigating
the possibility of pharmacologically antagonising the KDEL recep-
tor as a tool to reduced intoxication by these toxins.
6. Regulation of KDEL receptor cycling
The retrograde transport of the KDEL receptor from the Golgi
complex to the ER can be modulated by the tyrosine kinase Src
and by serine/threonine protein kinase A (PKA). Src is the founding
member of the Src family kinases (SFKs), which are involved in the
regulation of several cellular functions, including cell proliferation,
survival, differentiation, migration, cytoskeletal rearrangements,
secretion and other biological activities. SFKs have also been
shown to be downstream effectors of GPCRs and tyrosine kinase
receptors [61,62]. Interestingly, Src participates in different aspects
of KDEL receptor functioning, including modulation of its retro-
grade transport [63]. Speciﬁcally, the overexpression of a constitu-
tively active Src redistributes the KDEL receptor out of the Golgi
complex, and the trafﬁcking rate of the Pseudomonas exotoxin from
the Golgi complex to the ER is reduced. It has thus been argued that
decreased availability of the KDEL receptor in the Golgi complex
slows the rate of retrograde transport of the Pseudomonas exotoxin
[63].
PKA is a central player in the cAMP–PKA signalling pathway,
and it is involved in the regulation of many trafﬁcking steps,
including Golgi-to-ER retrograde transport, intra-Golgi transport
and Golgi-to-plasma membrane transport [64,65]. Of note, retro-
grade transport of the KDEL receptor depends on its phosphoryla-
tion by PKA (Fig. 1), in a model again reminiscent of the regulation/
internalisation of GPCRs. Phosphorylation of the KDEL receptor by
PKA on S209 exposes a hidden dilysine motive that is necessary for
the interaction of the KDEL receptor with the COPI/ARFGAP1 com-
plex and subsequent retrograde transport. Replacement of this
S209 with the non-phosphorylatable alanine markedly affects ret-
rograde transport of the KDEL receptor [48]. Many questions, how-
Fig. 1. Model of the KDEL receptor signalling functions and their regulation. Chaperones (the KDEL ligands) containing KDEL sequences (red, umbrella-shaped) can leave the
ER during normal anterograde transport or cell stress. On arrival at the cis-Golgi, they bind to the KDEL receptor, triggering phosphorylation of SFKs (p-SFKs) and p38 MAPKs
(p-p38 MAPKs). SFK activation is required for Golgi-to-plasma-membrane transport, and it appears relevant for the regulation of other cellular functions, while activation of
MAPK signalling can promote cell survival. Cross-talk of the KDEL receptor with PKA arises via PKA-dependent phosphorylation of the C-terminal of the KDEL receptor, which
also appears to be relevant for the modulation of COPI-dependent retrograde transport of the KDEL receptor.
3868 M. Capitani, M. Sallese / FEBS Letters 583 (2009) 3863–3871ever, still remain unanswered. For instance, how and when PKA is
activated, how KDEL receptor phosphorylation is coordinated with
the needs of retrograde transport, and what are the players in-
volved in this signalling pathway.
7. The KDEL receptor participates in the ER stress response
Since its discovery in yeast, it has become apparent that the
KDEL receptor has additional functions besides its chaperone-re-
trieval activity. This also arose as the erd2-deleted mutant yeast
phenotypes (Golgi-transport impairment, glycosylation defects,
lethality) cannot be explained on the basis of chaperone leakage
alone.
The functions that are now attributed to the KDEL receptor in-
clude a role in the regulation of ER quality control [66], which is
a mechanism to ensure that only correctly folded proteins are ex-ported from ER. An increase in misfolded proteins in the ER results
in the ER stress response, which activates several signalling path-
ways, leading to overexpression of ER chaperones, inhibition of
protein synthesis, and increased ER-associated degradation of mis-
folded proteins. As a result, activation of the ER stress response
might be either cytoprotective or proapoptotic for a cell, although
the molecular mechanisms that discriminate between these two
fates are poorly understood.
Aoe and co-workers (2003) reported that the KDEL receptor is
associated with stress-dependent activation of p38 mitogen-acti-
vated protein kinases (MAPKs; Fig. 1) and c-Jun amino-terminal ki-
nases (JNKs) [67]. Indeed, expression of the R169N-mutated KDEL
receptor suppresses ER-stress-response-dependent activation of
p38 and JNK1, but not of JNK2, indicating that besides its retrieval
activity, the KDEL receptor can modulate MAPK signalling. These
cells cannot recognise and retrieve chaperones to the ER [34] be-
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[67].
Since MAPK signalling has been implicated in a variety of pro-
cesses, such as cell development, differentiation, survival and
death [68], it is conceivable that KDEL-receptor-dependent modu-
lation of the MAPK signalling pathway is important in both physi-
ological and pathological processes.
8. KDEL receptor function in the animal model
Although the role of the KDEL receptor in yeast and mammalian
cells has been widely investigated, its function in a wider context
such as in whole organisms remains poorly explored. To address
the function of the KDEL receptor in vivo, Aoe and co-workers
(2004) generated a transgenic mouse that stably expressed the
D193N-mutant of the KDEL receptor, which acts as a dominant
negative versus the wild-type KDEL receptor [19,34,69]. This
D193N-mutant KDEL receptor is characterised by impaired traf-
ﬁcking from the Golgi complex to the ER, and it also impairs in-
tra-Golgi and post-Golgi transport [19,34]. Furthermore, in line
with its involvement in ER quality control, this KDEL receptor also
accumulates ubiquitinated protein aggregates, and perturbs ER-to-
Golgi transport [69].
Transgenic mice expressing this D193N mutant KDEL receptor
have problems in breathing, show reduced movement, and gener-
ally die at about 14 months. These symptoms arise from a dilated
cardiomyopathy that is characterised by increased ventricular
chamber size, reduced contractility of the heart, and enlarged
cardiomyocytes. The cardiomyocytes show different signs that
are typical of chronic heart failure, including proliferation of the
sarcoplasmic reticulum, formation of abundant misfolded protein
aggregates, reduced density of functional L-type Ca2+ channels,
and overexpression of atrial natriuretic factor. Further to this, the
presence of interstitial ﬁbrosis and the overproduction of the proa-
poptotic transcription factor CHOP indicate that mutation of the
KDEL receptor can render the heart more sensitive to ER stress,
thus promoting apoptotic cell death and the development of a di-
lated cardiomyopathy [69].
9. The KDEL receptor triggers activation of Src family kinases
A recent study from our laboratory has provided conclusive evi-
dence of the signal transduction abilities of the KDEL receptor. We
have demonstrated that upon arrival of incoming trafﬁc at the Golgi
complex, KDEL receptor engagement triggers activation of SFKs on
the Golgi complex (Fig. 1) [1,19,70]. The central role of the KDEL
receptor in this process was revealed by using multiple approaches,
including the use of the D193N dominant-negative mutant of the
KDEL receptor, microinjection of an antibody against the cytosolic
tail of theKDEL receptor, andknock-downof theKDEL receptorusing
siRNAs. These approaches all markedly reduced the activation of
SFKs on theGolgi complex that accompanied the arrival of incoming
trafﬁc from the ER. We also provided evidence that activation of the
KDEL receptor is sufﬁcient to stimulate SFKs on the Golgi complex,
for example, by ligands arriving at the Golgi complex anterogradely
from the ER or retrogradely from the endocytic compartment, or
with the simple overexpression of the KDEL receptor (a condition
previously shown to self-activate the KDEL receptor).
In our model, the signal generated by the incoming trafﬁc at the
Golgi complex is provided by the chaperones that exit the ER dur-
ing the secretory process. When these reach the cis-Golgi compart-
ment, they bind to the KDEL receptor, which thus triggers
activation of SFKs, the tyrosine kinase activities of which are essen-
tial for the progression of cargo molecules through and from the
Golgi complex to the plasma membrane (Fig. 1) [1,19].In summary, we believe that a system is in place in the cell that
can sense the amount of incoming trafﬁc at the Golgi complex.
Although we cannot at this stage formally exclude that other cellu-
lar compartments are targeted by this signalling, the transmission
of this information from the incoming cargo prepares the Golgi
complex itself to handle the arriving cargo and to ultimately send
it on towards the correct ﬁnal destinations. Thus far, the molecular
players involved in the signal transduction from the KDEL receptor
to the SFKs remain unknown, as do the SFK effectors that are in-
volved in the regulation of Golgi transport. However, considering
the topological organisation of the KDEL receptor and our unpub-
lished data that heterotrimeric G-proteins can interact with the
KDEL receptor, we believe that the KDEL receptor transduces sig-
nals through a mechanism similar to that of the GPCRs.10. Puzzling KDEL receptor interactors
Most of the known KDEL receptor interactors reported above
are consistent with the established cycling of the KDEL receptor
between the ER and the Golgi complex for the recovery of KDEL-
containing chaperones that have ‘escaped’ from the ER. However,
systematic analyses in yeast and human have revealed unexpected
genetic and physical KDEL receptor partners, which would suggest
additional functional roles for the KDEL receptor. Here, we report
the identiﬁcation of some of these unexpected KDEL receptor
partners.
The ﬁrst genetic screen aimed at identifying the suppressor of
ERD2 deletion (see above) identiﬁed three proteins involved in
the ER-Golgi transport pathway (SED2, SED4, SED5), along with a
stress-response gene (SED1), a gene involved in the synthesis of
ergosterol (SED6), and a gene involved in the formation of GPI an-
chors (SED3) [10]. Fields and co-workers [71] later revealed seven
additional KDEL receptor physical partners: three cell-membrane
permeases (TAT1, TPO3 and CAN1, speciﬁc for tryptophan, poly-
amine and arginine, respectively); a cell membrane glucanosyl-
transferase (GAS3); a subunit of the signal peptide recognition
system (SPC1); a protein involved in the formation of GPI anchors
(GPI8); and a protein involved in ergosterol synthesis (ERG25).
Notably, the latter two interactors are consistent with previously
reported genetic screening results [10].
With the aim of analysing the functioning of the early secretory
pathway in yeast, another study reported that two subunits of the
co-chaperone complex involved in the folding of microtubules
(GIM3 and GIM4) have epistatic relationships with the KDEL recep-
tor [72]. In addition, the KDEL receptor has a synthetic lethal rela-
tionship with Ire1p, an ER protein crucial for the unfolded protein
response [73].
Regarding the mammalian KDEL receptor, a mass-spectrome-
try-based study that was aimed at providing a better understand-
ing of the functions of potentially disease-associated human genes
found the KDEL receptor as a partner of four new proteins [74]:
Serinc3, a protein involved in the metabolism of serine at the plas-
ma membrane; BZW1, a leucine-zipper protein potentially in-
volved in transcription regulation; NEK6, a serine/threonine
kinase involved in mitosis progression that regulates the formation
of the mitotic spindle; and WBP5, the function of which remains to
be clariﬁed.
In conclusion, there are at least 14 KDEL receptor partners for
which the potential functions do not appear to be compatible with
the known primary role of the KDEL receptor, thus suggesting
that it has novel roles in the functioning of the cell. We can, for in-
stance, hypothesise involvement of the KDEL receptor in lipid
metabolism, through its relationships with proteins that participate
in the formation of GPI anchors and in cholesterol synthesis. Fur-
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and with NEK kinase would suggest an involvement in cell growth.
A word of caution is needed, however, as many of these inter-
actors arise from genetic studies, and might thus represent very
indirect relationships. Physical interaction data has been ob-
tained through large-scale, two-hybrid screening, which again is
prone to generating false-positive results. Furthermore, the inter-
actors of the human KDEL receptor identiﬁed by mass spectrom-
etry analysis and co-immunoprecipitation of overexpressed baits
could still represent false-positives, despite all of the possible
controls that have been included; in addition, this approach iden-
tiﬁes direct and indirect KDEL receptor partners as parts of large
complexes.
Despite these potential pitfalls, we believe that a strong case
can be made for additional functions of the KDEL receptor,
although these require further investigation.11. Concluding remarks
The KDEL receptor represents an important class of proteins
that is necessary for the recovery of ER-resident chaperones from
the late secretory compartments back to the ER. This role can be
envisaged as part of a wider function in the coordination of ER
quality control and the unfolded protein response. In addition,
the KDEL receptor synchronises the whole secretory system, since
the binding of chaperones also triggers a signalling cascade that is
involved in the regulation of secretion at the Golgi complex. At
present however, some of the identiﬁed KDEL receptor interactors
remain difﬁcult to position within this scenario, thus suggesting
additional KDEL receptor function(s).
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